ISCT Sets New Standard with ANAB Accreditation in CGT Training
ISCT Achieves Groundbreaking ANAB Accreditation
The ISCT Institute of Training & Development, a vital division of the International Society for Cell and Gene Therapy (ISCT), has recently accomplished a significant milestone by becoming the first organization in the cell and gene therapy (CGT) field to receive accredited recognition from the ANSI National Accreditation Board (ANAB). This remarkable achievement emphasizes ISCT's commitment to enhancing workforce development within a sector that is rapidly evolving and requires skilled professionals.
Importance of ANAB Accreditation
The ANAB accreditation signifies that ISCT meets rigorous international standards in training quality. This recognition followed a thorough audit, adhering to the ANSI/ASTM E2659-18 standard, which scrutinizes the efficacy of education programs globally. By establishing robust quality management systems and ensuring consistent learner assessments, ISCT's training programs equip participants with the technical skills and credibility needed in a highly competitive field.
Commitment to Workforce Development
Queenie Jang, BSc (Pharmacy), MBA, the CEO of ISCT, expressed that this accreditation reflects the organization’s dedication to being a leading force in CGT workforce development. She mentioned, "Identifying the shortage of skilled professionals as an impediment to progress in the CGT sector has led ISCT to make substantial investments in our training initiatives over recent years. We are eager to expand partnerships that will facilitate the introduction of new programs to meet the industry's evolving demands."
Strategic Partnerships for Skills Development
ISCT's holistic approach to training focuses on bridging the gap between industry demands and the readiness of the workforce. The Institute aims to furnish learners with essential skills applicable to clinical, manufacturing, and regulatory roles, ensuring that the CGT sector advances scientific innovation and delivers cutting-edge therapies.
Collaboration with Industry Leaders
Emily Hopewell, PhD, Co-Chair of the ISCT Workforce Development Committee, emphasized the collaborative nature of their programs. They have been designed with contributions from industry experts and partners such as the NSF Engineering Research Center for Cell Manufacturing Technologies and Standards Coordinating Body. This proactive approach underlines ISCT’s commitment to developing timely and relevant training that addresses skill gaps within the CGT field.
Accredited Training Programs
Among the key training programs that have received ANAB accreditation are the courses, "Cell Product Handling and Regulatory 101," "Essentials of Cell Therapy Product Manufacturing," and "The Principles and Applications of Cell Therapy Biomanufacturing, Characterization, and Regulatory." With this accreditation, participants gain education that meets the high standards expected by employers and regulatory agencies, ensuring that the skills learned are transferable and recognized across the globe.
The Importance of Quality in Professional Development
ISCT President, Miguel Forte, MD, PhD, commented on the significance of ANAB accreditation by stating, "This guarantee ensures that our learners develop skills that are not only standardized but also hold worldwide respect, which helps address crucial skills shortages and aids individuals in their career development."
The Institute currently offers an impressive range of 11 accredited training programs that encompass clinical training and harmonized laboratory practices. Plans are in place to introduce new courses that focus on emerging topics such as induced Pluripotent Stem Cells (iPSCs) and CAR T-cell therapies. This proactive approach ensures the curriculum remains relevant and aligned with industry advancements.
About the ISCT Institute of Training & Development
Established in 2023, the ISCT Institute aims to tackle the pressing skills gaps in the cell and gene therapy sector. By utilizing the expertise of over 4,000 ISCT members, including key opinion leaders from academia and industry, the Institute plays a crucial role in shaping the future workforce of CGT.
Through its extensive offerings of more than 11 training programs accredited internationally, it collaborates with respected centers of excellence to provide tailored educational solutions. These programs are focused on meeting the sophisticated demands of the field, ensuring continuous evolution and adaptation in teaching methodologies to support learners with the skills they need for success.
About ISCT
Founded in 1992, the International Society for Cell & Gene Therapy (ISCT) is dedicated to advancing the field of CGT through a collaborative environment that unites clinicians, regulators, researchers, and industry partners. With a commitment to developing safe and effective therapies to enhance patient lives globally, ISCT remains at the forefront of this dynamic field.
ISCT is not just a hub for professionals; it represents a vast network comprising over 4,000 experts spread across numerous countries. By fostering strong collaborations and relationships with global regulatory bodies, academic institutions, and industry leaders, ISCT is paving the way for groundbreaking research that advances patient care.
Frequently Asked Questions
What is the significance of ANAB accreditation for ISCT?
ANAB accreditation confirms that ISCT meets high international training standards, enhancing the credibility and recognition of its programs.
How many training programs does ISCT currently offer?
The Institute offers 11 accredited training programs designed to meet the needs of the cell and gene therapy sector.
Who are the key partners involved in ISCT’s training initiatives?
ISCT collaborates with industry leaders, including the NSF Engineering Research Center for Cell Manufacturing Technologies and Standards Coordinating Body.
What types of roles do ISCT’s training programs prepare individuals for?
Participants are equipped with skills for clinical, manufacturing, and regulatory roles within the cell and gene therapy industry.
When was the ISCT Institute of Training & Development established?
The Institute was founded in 2023, focusing on training and development in the CGT sector.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Invesco Funds Announce Monthly Dividend Payments for Investors
- Experience Napa Valley's Finest at Boca Raton's Culinary Event
- Hepsiburada's Latest Move: Launching New Asset-Backed Securities
- Major Outcomes from iClick Interactive's Annual General Meeting
- Exciting New Dining Experiences Coming to The Union Area
- Innovative Hair Loss Treatment Shows Promising Results
- Experience the Magic of Paris with Bath & Body Works' New Collection
- Saudi Arabia Invites Global Leaders to Join MIPF 2024 Forum
- Discover the Advanced ZEISS KINEVO 900 S for Neurosurgery
- South University Students Honored with NMHWAC Fellowship Opportunity
Recent Articles
- Catalyst Acoustics Group Enters New Chapter with KPS Capital Partners
- Acuity Brands Prepares for Q4 Earnings with Analyst Ratings
- Celebrating Trucking Heroes: TrueBlue's Respect the Drive Month
- Workstream Revolutionizes Payroll for Hourly Workers with New Suite
- Explore Genetics with PNRI's Engaging New Podcast Series
- Captivision Increases Revenue and Strengthens Financial Position
- CytoMed Therapeutics Unveils Financial Results and Progress Updates
- McDermott Secures Major LNG Project Contract for Growth
- Antelope Enterprise Reports 2024 Financial Results with New Ventures
- HungryPanda Secures $55 Million to Expand Global Reach
- Leap Therapeutics Completes Enrollment in DKN-01 Study for Cancer
- Empowering Cybersecurity: Strong Passwords for All
- TapestryHealth Welcomes New Faces to Board of Directors
- NetSPI Celebrated as Top Workplace for 2024 by Oregonian
- NRx Pharmaceuticals Achieves Stability Milestone for NRX-100
- Gogo's Acquisition of Satcom Direct: A Game-Changer in Aviation
- Empowering Women in HVACR: Highlights from Annual Convention
- British Vlogger Highlights Dunhuang's Cultural Greatness
- EchoStar Corporation's Exchange Offers for DBS Notes Explained
- Transforming Life Sciences: Magnolia and Veeva's New Integration
- Domino's Offers Half Price Pizza for National Pizza Month
- Eller Group Welcomes Ross Ramsey: A New Dimension in Strategy
- Businesses Face Rising Threats from Deepfake Scams in 2024
- Impressive Growth of the MICE Industry: Key Insights and Trends
- Global Wire-Rope Market Poised for Rapid Growth by 2032
- Future Growth of Electric Trolling Motors Estimated at 3.6% CAGR
- Navient's New Strategy Sparks Hope Amid Legacy Loan Challenges
- Zeta Global Holdings: Increasing Growth and Market Confidence
- Exploring the Future of Behavioral Rehabilitation Market Growth
- Jack in the Box Expands Reach with 12 New Locations in Chicago
- Growth Projections for Bariatric Surgery Devices Through 2033
- Tide Capital Anticipates Crypto Surge After Fed Rate Cuts
- Equity Funds Experience Record Inflows Amid Market Changes
- PCE Data Sparks Interest in Potential Fed Rate Cuts Soon
- Talus Network's Nexus Revolutionizes Autonomous AI on Blockchain
- WPP Energy Revolutionizes Energy Sector with Innovations
- Prime Medicine Collaborates with Bristol Myers Squibb for Innovative T-Cell Therapies
- Tonix Pharmaceuticals Shares Insights on Long COVID Workshop
- Mercury Systems Boosts KC-46A Tanker Fleet with Enhanced Tech
- CytoMed Therapeutics Updates on Clinical Progress and Finances
- BioStem Technologies Seeks Nasdaq Uplisting with Form 10 Registration
- Exploring Nurix Therapeutics' Innovations at a Leading Conference
- Sable Resources Expands Copper Queen Project with New Discoveries
- Exploring Investment Opportunities in Consumer Discretionary ETFs
- Captivision Inc. Sees 22% Revenue Growth in Recent Results
- Market Reflections: Powell's Insights and Global Trends
- Akero Therapeutics to Showcase Innovations at Upcoming Virtual Conference
- Exploring Growth Stocks: Broadcom and AMD Amid Market Bounce
- Perspective Therapeutics Shares Insights at European Congress
- BioCryst Pharmaceuticals Secures $69 Million Influenza Contract